Sumitovant Biopharma, Inc.
1 clinical trials · Sponsor
◉ Watch Sumitovant Biopharma, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects (NCT05226923) | Sumitovant Biopharma, Inc. | 2022-01-12 |
Track Sumitovant Biopharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.